Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Scand J Rheumatol ; 26(1): 55-7, 1997.
Article in English | MEDLINE | ID: mdl-9057803

ABSTRACT

Antineutrophil cytoplasmic autoantibodies (ANCA) were sought in 43 sera from 39 Mexican patients with typical Takayasu's arteritis (TA), (5 with active and 34 with inactive disease), and in a comparative group comprising 50 sera. Results were negative in all cases. This suggests that ANCA are not a serologic feature in TA per se, even during its active stage. ANCA positivity in TA, when present, may be a non-related phenomenon and probably identifies a subset of patients with atypical forms of TA or a polyangiitis overlap syndrome.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/analysis , Takayasu Arteritis/immunology , Adult , Cross-Sectional Studies , Female , Humans , Male , Mexico , Prevalence , Takayasu Arteritis/blood , Takayasu Arteritis/pathology
2.
J Pediatr ; 111(6 Pt 2): 1063-8, 1987 Dec.
Article in English | MEDLINE | ID: mdl-3681569

ABSTRACT

Thirteen patients with severe steroid-resistant or steroid-dependent forms of systemic lupus erythematosus were treated with cyclosporine (average dose 5 mg/kg/d) for an average period of 12 months. In eight patients the disease activity decreased, as substantiated by the reduction in the amount of steroid required to control the clinical manifestations. Interruption of cyclosporine treatment was associated with relapse or worsening of disease in five subjects. These favorable clinical results occurred in the absence of changes in the levels of antinuclear, anti-double-stranded deoxyribonucleic acid autoantibodies or plasma complement components; plasma IgG concentration increased significantly. Six patients had signs of moderate cyclosporine nephrotoxicity that disappeared when the administration of the drug was discontinued. Hypertension was the most serious side effect observed in eight subjects; in every case it was controlled by antihypertensive medicine. These data indicate that cyclosporine may be beneficial in the treatment of some patients with severe forms of systemic lupus erythematosus.


Subject(s)
Cyclosporins/therapeutic use , Lupus Erythematosus, Systemic/drug therapy , Adolescent , Adult , Autoantibodies/analysis , Cyclosporins/adverse effects , Drug Evaluation , Drug Resistance , Female , Humans , Hypertension/chemically induced , Kidney Diseases/chemically induced , Lupus Erythematosus, Systemic/immunology , Male , Middle Aged , Prednisone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL